Angiodynamics (ANGO) Other financing activities (2010 - 2026)

Angiodynamics (ANGO) has reported Other financing activities for 16 consecutive years, with $716000.0 the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities fell 20.0% year-over-year to $716000.0; the trailing twelve-month figure through Feb 2026 stood at $1.8 million (up 13.4% YoY), and the FY2019 full-year result was $2.0 million, down 31.13% from the prior year.
• Other financing activities climbed to $716000.0 in Q1 2026 per ANGO's latest filing, from $234000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $941000.0 in Q1 2023 and bottomed at -$352000.0 in Q4 2023.
• Historically, Other financing activities has averaged $346000.0 across 5 years, with a median of $234000.0 in 2025.
• The sharpest annual moves came in 2023 and 2025: Other financing activities tumbled 337.84% in 2023, then soared 444.19% in 2025.
• Over 5 years, Other financing activities stood at $148000.0 in 2022, then sank by 337.84% to -$352000.0 in 2023, then soared by 98.58% to -$5000.0 in 2024, then surged by 4780.0% to $234000.0 in 2025, then jumped by 205.98% to $716000.0 in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $716000.0, $234000.0, and $895000.0 for Q1 2026, Q3 2025, and Q1 2025 respectively.